சிமாதம் 2022க்கான சிறந்த செயல்திறன் மியூச்சுவல் ஃபண்டுகள்

Updated on May 12, 2026 , 38075 views

கீழே உள்ள அளவுகோல்களின் அடிப்படையில் நாங்கள் தேர்ந்தெடுத்துள்ளோம்சிறந்த செயல்திறன் மியூச்சுவல் ஃபண்டுகள் சிமாதம், 2022. குறைந்தபட்சம் நிதியை வடிகட்டியுள்ளோம்100 கோடி அனைத்து வகைகளிலிருந்தும் நிர்வாகத்தின் கீழ் உள்ள சொத்துக்கள்.

Ready to Invest?
Talk to our investment specialist

அளவுகோல்கள்

AUM > 100 கோடி
நிதி வயது > 1 வருடம்
அனைத்து வகைகளிலிருந்தும் நிதி
1 மாத வருமானத்தில் வரிசைப்படுத்தப்பட்டது.
நிதிகளின் வகைகள்
- பங்கு
- கடன்
- கலப்பின
- தங்கம்
- உலகளாவிய நிதி

ஆன்லைனில் மியூச்சுவல் ஃபண்டுகளில் முதலீடு செய்வது எப்படி?

Fincash.com இல் வாழ்நாள் முழுவதும் இலவச முதலீட்டுக் கணக்கைத் திறக்கவும்.

உங்கள் பதிவு மற்றும் KYC செயல்முறையை முடிக்கவும்

ஆவணங்களைப் பதிவேற்றவும் (PAN, ஆதார் போன்றவை).மேலும், நீங்கள் முதலீடு செய்ய தயாராக உள்ளீர்கள்!

தொடங்குங்கள்

முதல் 11 சிறந்த மியூச்சுவல் ஃபண்டுகள் 2022 சிமாதம்

Fund	NAV	Net Assets (Cr)	Min Investment	Min SIP Investment	1 MO (%)	3 MO (%)	6 MO (%)	1 YR (%)	3 YR (%)	5 YR (%)	2024 (%)
Kotak Global Emerging Market Fund Growth	₹40.215 ↑ 0.24	₹935	5,000	1,000	15	16.8	32.2	70.6	28.4	12.2	39.1
PGIM India Euro Equity Fund Growth	₹24.98 ↑ 0.14	₹1,263	5,000	1,000	14.9	19.5	37	59.6	32.3	7.6	18.3
DSP US Flexible Equity Fund Growth	₹94.0482 ↑ 0.11	₹1,055	1,000	500	14.4	22.4	26.6	63.3	29.6	19.3	33.8
Franklin Asian Equity Fund Growth	₹43.7068 ↑ 0.19	₹400	5,000	500	14.3	12.6	23.8	50.3	20.7	7	23.7
Edelweiss Emerging Markets Opportunities Equity Off-shore Fund Growth	₹28.552 ↑ 0.21	₹188	5,000	1,000	13.9	19	35.7	78.4	28.7	10.3	41.1
PGIM India Global Agribusiness Offshore Fund Growth	₹52.32 ↑ 0.70	₹1,511	5,000	1,000	12.3	17.5	12	26.1	20.9	10.2	7.9
Franklin India Feeder - Franklin U S Opportunities Fund Growth	₹91.226 ↑ 0.96	₹4,408	5,000	500	11	17.2	16.1	28	25.6	13.3	11.4
UTI Healthcare Fund Growth	₹307.133 ↑ 6.45	₹1,056	5,000	500	9.9	10	6	13.2	27.1	14.4	-3.1
TATA India Pharma & Healthcare Fund Growth	₹31.5869 ↑ 0.54	₹1,229	5,000	150	9.5	7.2	2.2	7.5	23.9	14.1	-4.9
Nippon India Pharma Fund Growth	₹542.651 ↑ 10.80	₹7,898	5,000	100	9.2	8	4.5	9.9	24	13.6	-3.3
DSP World Energy Fund Growth	₹30.7211 ↑ 0.51	₹104	1,000	500	8.9	15.3	33.3	71.2	20	14.2	39.2
Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 13 May 26

Research Highlights & Commentary of 11 Funds showcased

Commentary	Kotak Global Emerging Market Fund	PGIM India Euro Equity Fund	DSP US Flexible Equity Fund	Franklin Asian Equity Fund	Edelweiss Emerging Markets Opportunities Equity Off-shore Fund	PGIM India Global Agribusiness Offshore Fund	Franklin India Feeder - Franklin U S Opportunities Fund	UTI Healthcare Fund	TATA India Pharma & Healthcare Fund	Nippon India Pharma Fund	DSP World Energy Fund
Point 1	Lower mid AUM (₹935 Cr).	Upper mid AUM (₹1,263 Cr).	Lower mid AUM (₹1,055 Cr).	Bottom quartile AUM (₹400 Cr).	Bottom quartile AUM (₹188 Cr).	Upper mid AUM (₹1,511 Cr).	Top quartile AUM (₹4,408 Cr).	Lower mid AUM (₹1,056 Cr).	Upper mid AUM (₹1,229 Cr).	Highest AUM (₹7,898 Cr).	Bottom quartile AUM (₹104 Cr).
Point 2	Established history (18+ yrs).	Established history (18+ yrs).	Established history (13+ yrs).	Established history (18+ yrs).	Established history (11+ yrs).	Established history (16+ yrs).	Established history (14+ yrs).	Oldest track record among peers (26 yrs).	Established history (10+ yrs).	Established history (21+ yrs).	Established history (16+ yrs).
Point 3	Rating: 3★ (upper mid).	Rating: 2★ (lower mid).	Top rated.	Rating: 5★ (top quartile).	Rating: 3★ (upper mid).	Rating: 1★ (bottom quartile).	Rating: 4★ (upper mid).	Rating: 1★ (bottom quartile).	Not Rated.	Rating: 2★ (lower mid).	Rating: 2★ (lower mid).
Point 4	Risk profile: High.	Risk profile: High.	Risk profile: High.	Risk profile: High.	Risk profile: High.	Risk profile: High.	Risk profile: High.	Risk profile: High.	Risk profile: High.	Risk profile: High.	Risk profile: High.
Point 5	5Y return: 12.20% (lower mid).	5Y return: 7.56% (bottom quartile).	5Y return: 19.31% (top quartile).	5Y return: 7.01% (bottom quartile).	5Y return: 10.29% (lower mid).	5Y return: 10.18% (bottom quartile).	5Y return: 13.31% (lower mid).	5Y return: 14.38% (top quartile).	5Y return: 14.13% (upper mid).	5Y return: 13.65% (upper mid).	5Y return: 14.20% (upper mid).
Point 6	3Y return: 28.38% (upper mid).	3Y return: 32.33% (top quartile).	3Y return: 29.63% (top quartile).	3Y return: 20.74% (bottom quartile).	3Y return: 28.74% (upper mid).	3Y return: 20.88% (bottom quartile).	3Y return: 25.56% (lower mid).	3Y return: 27.12% (upper mid).	3Y return: 23.93% (lower mid).	3Y return: 24.03% (lower mid).	3Y return: 20.00% (bottom quartile).
Point 7	1Y return: 70.56% (upper mid).	1Y return: 59.62% (upper mid).	1Y return: 63.34% (upper mid).	1Y return: 50.28% (lower mid).	1Y return: 78.40% (top quartile).	1Y return: 26.13% (lower mid).	1Y return: 28.01% (lower mid).	1Y return: 13.24% (bottom quartile).	1Y return: 7.53% (bottom quartile).	1Y return: 9.90% (bottom quartile).	1Y return: 71.21% (top quartile).
Point 8	Alpha: -0.92 (upper mid).	1M return: 14.90% (top quartile).	Alpha: -1.33 (lower mid).	Alpha: 0.00 (upper mid).	Alpha: 4.90 (top quartile).	1M return: 12.32% (lower mid).	Alpha: -7.19 (lower mid).	Alpha: -1.12 (lower mid).	Alpha: -7.59 (bottom quartile).	Alpha: 0.02 (top quartile).	Alpha: 0.00 (upper mid).
Point 9	Sharpe: 1.75 (upper mid).	Alpha: -14.64 (bottom quartile).	Sharpe: 1.98 (upper mid).	Sharpe: 1.02 (lower mid).	Sharpe: 2.06 (top quartile).	Alpha: -25.56 (bottom quartile).	Sharpe: 0.99 (lower mid).	Sharpe: -0.35 (bottom quartile).	Sharpe: -0.53 (bottom quartile).	Sharpe: -0.25 (bottom quartile).	Sharpe: 3.63 (top quartile).
Point 10	Information ratio: -0.73 (bottom quartile).	Sharpe: 1.82 (upper mid).	Information ratio: -0.27 (upper mid).	Information ratio: 0.00 (top quartile).	Information ratio: -0.54 (lower mid).	Sharpe: -0.04 (lower mid).	Information ratio: -1.70 (bottom quartile).	Information ratio: -0.33 (upper mid).	Information ratio: -0.64 (lower mid).	Information ratio: -0.77 (bottom quartile).	Information ratio: 0.00 (top quartile).

Kotak Global Emerging Market Fund

Lower mid AUM (₹935 Cr).
Established history (18+ yrs).
Rating: 3★ (upper mid).
Risk profile: High.
5Y return: 12.20% (lower mid).
3Y return: 28.38% (upper mid).
1Y return: 70.56% (upper mid).
Alpha: -0.92 (upper mid).
Sharpe: 1.75 (upper mid).
Information ratio: -0.73 (bottom quartile).

PGIM India Euro Equity Fund

Upper mid AUM (₹1,263 Cr).
Established history (18+ yrs).
Rating: 2★ (lower mid).
Risk profile: High.
5Y return: 7.56% (bottom quartile).
3Y return: 32.33% (top quartile).
1Y return: 59.62% (upper mid).
1M return: 14.90% (top quartile).
Alpha: -14.64 (bottom quartile).
Sharpe: 1.82 (upper mid).

DSP US Flexible Equity Fund

Lower mid AUM (₹1,055 Cr).
Established history (13+ yrs).
Top rated.
Risk profile: High.
5Y return: 19.31% (top quartile).
3Y return: 29.63% (top quartile).
1Y return: 63.34% (upper mid).
Alpha: -1.33 (lower mid).
Sharpe: 1.98 (upper mid).
Information ratio: -0.27 (upper mid).

Franklin Asian Equity Fund

Bottom quartile AUM (₹400 Cr).
Established history (18+ yrs).
Rating: 5★ (top quartile).
Risk profile: High.
5Y return: 7.01% (bottom quartile).
3Y return: 20.74% (bottom quartile).
1Y return: 50.28% (lower mid).
Alpha: 0.00 (upper mid).
Sharpe: 1.02 (lower mid).
Information ratio: 0.00 (top quartile).

Edelweiss Emerging Markets Opportunities Equity Off-shore Fund

Bottom quartile AUM (₹188 Cr).
Established history (11+ yrs).
Rating: 3★ (upper mid).
Risk profile: High.
5Y return: 10.29% (lower mid).
3Y return: 28.74% (upper mid).
1Y return: 78.40% (top quartile).
Alpha: 4.90 (top quartile).
Sharpe: 2.06 (top quartile).
Information ratio: -0.54 (lower mid).

PGIM India Global Agribusiness Offshore Fund

Upper mid AUM (₹1,511 Cr).
Established history (16+ yrs).
Rating: 1★ (bottom quartile).
Risk profile: High.
5Y return: 10.18% (bottom quartile).
3Y return: 20.88% (bottom quartile).
1Y return: 26.13% (lower mid).
1M return: 12.32% (lower mid).
Alpha: -25.56 (bottom quartile).
Sharpe: -0.04 (lower mid).

Franklin India Feeder - Franklin U S Opportunities Fund

Top quartile AUM (₹4,408 Cr).
Established history (14+ yrs).
Rating: 4★ (upper mid).
Risk profile: High.
5Y return: 13.31% (lower mid).
3Y return: 25.56% (lower mid).
1Y return: 28.01% (lower mid).
Alpha: -7.19 (lower mid).
Sharpe: 0.99 (lower mid).
Information ratio: -1.70 (bottom quartile).

UTI Healthcare Fund

Lower mid AUM (₹1,056 Cr).
Oldest track record among peers (26 yrs).
Rating: 1★ (bottom quartile).
Risk profile: High.
5Y return: 14.38% (top quartile).
3Y return: 27.12% (upper mid).
1Y return: 13.24% (bottom quartile).
Alpha: -1.12 (lower mid).
Sharpe: -0.35 (bottom quartile).
Information ratio: -0.33 (upper mid).

TATA India Pharma & Healthcare Fund

Upper mid AUM (₹1,229 Cr).
Established history (10+ yrs).
Not Rated.
Risk profile: High.
5Y return: 14.13% (upper mid).
3Y return: 23.93% (lower mid).
1Y return: 7.53% (bottom quartile).
Alpha: -7.59 (bottom quartile).
Sharpe: -0.53 (bottom quartile).
Information ratio: -0.64 (lower mid).

Nippon India Pharma Fund

Highest AUM (₹7,898 Cr).
Established history (21+ yrs).
Rating: 2★ (lower mid).
Risk profile: High.
5Y return: 13.65% (upper mid).
3Y return: 24.03% (lower mid).
1Y return: 9.90% (bottom quartile).
Alpha: 0.02 (top quartile).
Sharpe: -0.25 (bottom quartile).
Information ratio: -0.77 (bottom quartile).

DSP World Energy Fund

Bottom quartile AUM (₹104 Cr).
Established history (16+ yrs).
Rating: 2★ (lower mid).
Risk profile: High.
5Y return: 14.20% (upper mid).
3Y return: 20.00% (bottom quartile).
1Y return: 71.21% (top quartile).
Alpha: 0.00 (upper mid).
Sharpe: 3.63 (top quartile).
Information ratio: 0.00 (top quartile).

*இன் பட்டியல் கீழே உள்ளதுசிறந்த மியூச்சுவல் ஃபண்டுகள் சிமாதத்திற்கு, 2022 உடன்சொத்துக்கள் >= 100 கோடி

1. Kotak Global Emerging Market Fund

The investment objective of the scheme is to provide long-term capital appreciation by investing in an overseas mutual fund scheme that invests in a diversified portfolio of securities as prescribed by SEBI from time to time in global emerging markets.

Research Highlights for Kotak Global Emerging Market Fund

Lower mid AUM (₹935 Cr).
Established history (18+ yrs).
Rating: 3★ (upper mid).
Risk profile: High.
5Y return: 12.20% (lower mid).
3Y return: 28.38% (upper mid).
1Y return: 70.56% (upper mid).
Alpha: -0.92 (upper mid).
Sharpe: 1.75 (upper mid).
Information ratio: -0.73 (bottom quartile).

Below is the key information for Kotak Global Emerging Market Fund

Kotak Global Emerging Market Fund Growth
Launch Date	26 Sep 07
NAV (13 May 26)	₹40.215 ↑ 0.24 (0.60 %)
Net Assets (Cr)	₹935 on 31 Mar 26
Category	Equity - Global
AMC	Kotak Mahindra Asset Management Co Ltd
Rating	☆☆☆
Risk	High
Expense Ratio	1.64
Sharpe Ratio	1.75
Information Ratio	-0.73
Alpha Ratio	-0.92
Min Investment	5,000
Min SIP Investment	1,000
Exit Load	0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
30 Apr 21	₹10,000
30 Apr 22	₹8,265
30 Apr 23	₹8,084
30 Apr 24	₹9,162
30 Apr 25	₹9,590
30 Apr 26	₹15,911

Kotak Global Emerging Market Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹415,684.
Net Profit of ₹115,684 Invest Now

Returns for Kotak Global Emerging Market Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 13 May 26

Duration	Returns
1 Month	15%
3 Month	16.8%
6 Month	32.2%
1 Year	70.6%
3 Year	28.4%
5 Year	12.2%
10 Year
15 Year
Since launch	7.8%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	39.1%
2023	5.9%
2022	10.8%
2021	-15%
2020	-0.5%
2019	29.1%
2018	21.4%
2017	-14.4%
2016	30.4%
2015	-1.2%

Fund Manager information for Kotak Global Emerging Market Fund

Name	Since	Tenure
Arjun Khanna	9 May 19	6.98 Yr.

Data below for Kotak Global Emerging Market Fund as on 31 Mar 26

Equity Sector Allocation

Sector	Value
Technology	28.85%
Financial Services	23.43%
Consumer Cyclical	12.61%
Industrials	8.61%
Communication Services	7.1%
Basic Materials	7.09%
Energy	6.25%
Health Care	2.44%
Consumer Defensive	1.29%

Asset Allocation

Asset Class	Value
Cash	2.33%
Equity	97.67%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
CI Emerging Markets Class A Investment Fund \| -	99%	₹923 Cr	3,136,666 ↑ 495,164
Triparty Repo CBLO/Reverse Repo \| -	2%	₹16 Cr
Net Current Assets/(Liabilities) Net Current Assets \| -	0%	-₹4 Cr

2. PGIM India Euro Equity Fund

(Erstwhile DHFL Pramerica Top Euroland Offshore Fund)

The primary investment objective of the scheme is to generate long-term capital growth from a diversified portfolio of units of overseas mutual funds.

Research Highlights for PGIM India Euro Equity Fund

Upper mid AUM (₹1,263 Cr).
Established history (18+ yrs).
Rating: 2★ (lower mid).
Risk profile: High.
5Y return: 7.56% (bottom quartile).
3Y return: 32.33% (top quartile).
1Y return: 59.62% (upper mid).
1M return: 14.90% (top quartile).
Alpha: -14.64 (bottom quartile).
Sharpe: 1.82 (upper mid).
Information ratio: -0.15 (upper mid).

Below is the key information for PGIM India Euro Equity Fund

PGIM India Euro Equity Fund Growth
Launch Date	11 Sep 07
NAV (13 May 26)	₹24.98 ↑ 0.14 (0.56 %)
Net Assets (Cr)	₹1,263 on 28 Feb 26
Category	Others - Fund of Fund
AMC	Pramerica Asset Managers Private Limited
Rating	☆☆
Risk	High
Expense Ratio	1.63
Sharpe Ratio	1.82
Information Ratio	-0.15
Alpha Ratio	-14.64
Min Investment	5,000
Min SIP Investment	1,000
Exit Load	0-12 Months (1%),12 Months and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
30 Apr 21	₹10,000
30 Apr 22	₹6,619
30 Apr 23	₹5,681
30 Apr 24	₹7,107
30 Apr 25	₹7,875
30 Apr 26	₹12,549

PGIM India Euro Equity Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹367,070.
Net Profit of ₹67,070 Invest Now

Returns for PGIM India Euro Equity Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 13 May 26

Duration	Returns
1 Month	14.9%
3 Month	19.5%
6 Month	37%
1 Year	59.6%
3 Year	32.3%
5 Year	7.6%
10 Year
15 Year
Since launch	5%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	18.3%
2023	20.6%
2022	14.6%
2021	-35.6%
2020	-1.9%
2019	20.5%
2018	21.4%
2017	-10.3%
2016	14.6%
2015	-6.7%

Fund Manager information for PGIM India Euro Equity Fund

Name	Since	Tenure
Anandha Padmanabhan Anjeneyan	15 Feb 25	1.21 Yr.
Vivek Sharma	15 Feb 25	1.21 Yr.

Data below for PGIM India Euro Equity Fund as on 28 Feb 26

Asset Allocation

Asset Class	Value
Cash	4.48%
Equity	95.52%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
PGIM Jennison Emerging Mkts Eq USD W Acc Investment Fund \| -	98%	₹1,129 Cr	957,558 ↑ 32,733
Clearing Corporation Of India Ltd. CBLO/Reverse Repo \| -	2%	₹28 Cr
Net Receivables / (Payables) Net Current Assets \| -	1%	-₹8 Cr

3. DSP US Flexible Equity Fund

The primary investment objective of the Scheme is to seek capital appreciation by investing predominantly in units of BGF – USFEF. The Scheme may, at the discretion of the Investment Manager also invest in the units of other similar overseas mutual fund schemes, which may constitute a significant part of its corpus. The Scheme may also invest a certain portion of its corpus in money market securities and/or money market/liquid schemes of DSP BlackRock Mutual Fund, in order to meet liquidity requirements from time to time. However, there is no assurance that the investment objective of the Scheme will be realized. It shall be noted ‘similar overseas mutual fund schemes’ shall have investment objective, investment strategy and risk profile/consideration similar to those of BGF – USFEF.

Research Highlights for DSP US Flexible Equity Fund

Lower mid AUM (₹1,055 Cr).
Established history (13+ yrs).
Top rated.
Risk profile: High.
5Y return: 19.31% (top quartile).
3Y return: 29.63% (top quartile).
1Y return: 63.34% (upper mid).
Alpha: -1.33 (lower mid).
Sharpe: 1.98 (upper mid).
Information ratio: -0.27 (upper mid).

Below is the key information for DSP US Flexible Equity Fund

DSP US Flexible Equity Fund Growth
Launch Date	3 Aug 12
NAV (13 May 26)	₹94.0482 ↑ 0.11 (0.12 %)
Net Assets (Cr)	₹1,055 on 31 Mar 26
Category	Equity - Global
AMC	DSP BlackRock Invmt Managers Pvt. Ltd.
Rating	☆☆☆☆☆
Risk	High
Expense Ratio	1.55
Sharpe Ratio	1.98
Information Ratio	-0.27
Alpha Ratio	-1.33
Min Investment	1,000
Min SIP Investment	500
Exit Load	0-12 Months (1%),12 Months and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
30 Apr 21	₹10,000
30 Apr 22	₹10,180
30 Apr 23	₹10,762
30 Apr 24	₹12,948
30 Apr 25	₹12,899
30 Apr 26	₹22,240

DSP US Flexible Equity Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹493,520.
Net Profit of ₹193,520 Invest Now

Returns for DSP US Flexible Equity Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 13 May 26

Duration	Returns
1 Month	14.4%
3 Month	22.4%
6 Month	26.6%
1 Year	63.3%
3 Year	29.6%
5 Year	19.3%
10 Year
15 Year
Since launch	17.7%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	33.8%
2023	17.8%
2022	22%
2021	-5.9%
2020	24.2%
2019	22.6%
2018	27.5%
2017	-1.1%
2016	15.5%
2015	9.8%

Fund Manager information for DSP US Flexible Equity Fund

Name	Since	Tenure
Kaivalya Nadkarni	1 May 25	1 Yr.

Data below for DSP US Flexible Equity Fund as on 31 Mar 26

Equity Sector Allocation

Sector	Value
Technology	30.88%
Industrials	14.11%
Financial Services	12.33%
Communication Services	11.41%
Health Care	10.09%
Consumer Cyclical	9.41%
Energy	2.56%
Basic Materials	2.45%

Asset Allocation

Asset Class	Value
Cash	6.74%
Equity	93.24%
Debt	0.02%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
BGF US Flexible Equity I2 Investment Fund \| -	96%	₹1,013 Cr	1,817,053
Treps / Reverse Repo Investments CBLO/Reverse Repo \| -	4%	₹45 Cr
Net Receivables/Payables Net Current Assets \| -	0%	-₹2 Cr

4. Franklin Asian Equity Fund

An open-end diversified equity fund that seeks to provide medium to long term appreciation through investments primarily in Asian Companies / sectors (excluding Japan) with long term potential across market capitalisation.

Research Highlights for Franklin Asian Equity Fund

Bottom quartile AUM (₹400 Cr).
Established history (18+ yrs).
Rating: 5★ (top quartile).
Risk profile: High.
5Y return: 7.01% (bottom quartile).
3Y return: 20.74% (bottom quartile).
1Y return: 50.28% (lower mid).
Alpha: 0.00 (upper mid).
Sharpe: 1.02 (lower mid).
Information ratio: 0.00 (top quartile).

Below is the key information for Franklin Asian Equity Fund

Franklin Asian Equity Fund Growth
Launch Date	16 Jan 08
NAV (13 May 26)	₹43.7068 ↑ 0.19 (0.45 %)
Net Assets (Cr)	₹400 on 31 Mar 26
Category	Equity - Global
AMC	Franklin Templeton Asst Mgmt(IND)Pvt Ltd
Rating	☆☆☆☆☆
Risk	High
Expense Ratio	2.54
Sharpe Ratio	1.02
Information Ratio	0
Alpha Ratio	0
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-3 Years (1%),3 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
30 Apr 21	₹10,000
30 Apr 22	₹7,808
30 Apr 23	₹7,667
30 Apr 24	₹7,967
30 Apr 25	₹8,517
30 Apr 26	₹12,384

Franklin Asian Equity Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹367,070.
Net Profit of ₹67,070 Invest Now

Returns for Franklin Asian Equity Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 13 May 26

Duration	Returns
1 Month	14.3%
3 Month	12.6%
6 Month	23.8%
1 Year	50.3%
3 Year	20.7%
5 Year	7%
10 Year
15 Year
Since launch	8.4%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	23.7%
2023	14.4%
2022	0.7%
2021	-14.5%
2020	-5.9%
2019	25.8%
2018	28.2%
2017	-13.6%
2016	35.5%
2015	7.2%

Fund Manager information for Franklin Asian Equity Fund

Name	Since	Tenure
Sandeep Manam	18 Oct 21	4.54 Yr.
Shyam Sriram	26 Sep 24	1.59 Yr.

Data below for Franklin Asian Equity Fund as on 31 Mar 26

Equity Sector Allocation

Sector	Value
Technology	24.98%
Consumer Cyclical	19.65%
Financial Services	16.22%
Industrials	8.67%
Health Care	6.25%
Communication Services	5.14%
Real Estate	3.39%
Basic Materials	3.37%
Utility	2.39%
Energy	1.91%
Consumer Defensive	0.49%

Asset Allocation

Asset Class	Value
Cash	7.53%
Equity	92.47%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Taiwan Semiconductor Manufacturing Co Ltd (Technology) Equity, Since 31 Mar 09 \| 2330	9%	₹38 Cr	73,000 ↑ 3,000
Samsung Electronics Co Ltd (Technology) Equity, Since 31 Mar 08 \| 005930	5%	₹19 Cr	18,255
ICICI Bank Ltd (Financial Services) Equity, Since 31 Dec 25 \| ICICIBANK	4%	₹18 Cr	147,235 ↑ 22,962
Tencent Holdings Ltd (Communication Services) Equity, Since 31 Jul 14 \| 00700	4%	₹17 Cr	29,200 ↑ 2,700
HDFC Bank Ltd (Financial Services) Equity, Since 31 Dec 25 \| HDFCBANK	4%	₹16 Cr	212,624 ↓ -16,590
SK Hynix Inc (Technology) Equity, Since 30 Jun 20 \| 000660	3%	₹13 Cr	2,567
Larsen & Toubro Ltd (Industrials) Equity, Since 31 Mar 24 \| LT	3%	₹11 Cr	31,555
Torrent Pharmaceuticals Ltd (Healthcare) Equity, Since 31 Mar 24 \| TORNTPHARM	3%	₹10 Cr	23,997
Contemporary Amperex Technology Co Ltd Class A (Industrials) Equity, Since 30 Apr 24 \| 300750	2%	₹10 Cr	18,100
Max Healthcare Institute Ltd Ordinary Shares (Healthcare) Equity, Since 31 Mar 24 \| MAXHEALTH	2%	₹10 Cr	98,772 ↑ 21,627

5. Edelweiss Emerging Markets Opportunities Equity Off-shore Fund

The primary investment objective of the Scheme is to seek to provide long term capital growth by investing predominantly in the JPMorgan Funds - Emerging Markets Opportunities Fund, an equity fund which invests primarily in an aggressively managed portfolio of emerging market companies

Research Highlights for Edelweiss Emerging Markets Opportunities Equity Off-shore Fund

Bottom quartile AUM (₹188 Cr).
Established history (11+ yrs).
Rating: 3★ (upper mid).
Risk profile: High.
5Y return: 10.29% (lower mid).
3Y return: 28.74% (upper mid).
1Y return: 78.40% (top quartile).
Alpha: 4.90 (top quartile).
Sharpe: 2.06 (top quartile).
Information ratio: -0.54 (lower mid).

Below is the key information for Edelweiss Emerging Markets Opportunities Equity Off-shore Fund

Edelweiss Emerging Markets Opportunities Equity Off-shore Fund Growth
Launch Date	7 Jul 14
NAV (13 May 26)	₹28.552 ↑ 0.21 (0.74 %)
Net Assets (Cr)	₹188 on 31 Mar 26
Category	Equity - Global
AMC	Edelweiss Asset Management Limited
Rating	☆☆☆
Risk	High
Expense Ratio	1.04
Sharpe Ratio	2.06
Information Ratio	-0.54
Alpha Ratio	4.9
Min Investment	5,000
Min SIP Investment	1,000
Exit Load	0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
30 Apr 21	₹10,000
30 Apr 22	₹7,550
30 Apr 23	₹7,413
30 Apr 24	₹8,084
30 Apr 25	₹8,413
30 Apr 26	₹14,620

Edelweiss Emerging Markets Opportunities Equity Off-shore Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹395,578.
Net Profit of ₹95,578 Invest Now

Returns for Edelweiss Emerging Markets Opportunities Equity Off-shore Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 13 May 26

Duration	Returns
1 Month	13.9%
3 Month	19%
6 Month	35.7%
1 Year	78.4%
3 Year	28.7%
5 Year	10.3%
10 Year
15 Year
Since launch	9.2%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	41.1%
2023	5.9%
2022	5.5%
2021	-16.8%
2020	-5.9%
2019	21.7%
2018	25.1%
2017	-7.2%
2016	30%
2015	9.8%

Fund Manager information for Edelweiss Emerging Markets Opportunities Equity Off-shore Fund

Name	Since	Tenure
Bhavesh Jain	9 Apr 18	8.07 Yr.
Bharat Lahoti	1 Oct 21	4.58 Yr.

Data below for Edelweiss Emerging Markets Opportunities Equity Off-shore Fund as on 31 Mar 26

Equity Sector Allocation

Sector	Value
Technology	33.11%
Financial Services	23.18%
Consumer Cyclical	10.44%
Communication Services	9.34%
Industrials	5.83%
Energy	4.34%
Basic Materials	3.2%
Utility	1.14%
Real Estate	1.14%
Health Care	0.91%
Consumer Defensive	0.35%

Asset Allocation

Asset Class	Value
Cash	5.34%
Equity	93.99%
Debt	0.01%
Other	0.37%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
JPM Emerging Mkts Opps I (acc) USD Investment Fund \| -	96%	₹182 Cr	98,240 ↑ 1,035
Clearing Corporation Of India Ltd. CBLO/Reverse Repo \| -	4%	₹7 Cr
Net Receivables/(Payables) CBLO \| -	0%	₹0 Cr
Accrued Interest CBLO \| -	0%	₹0 Cr

6. PGIM India Global Agribusiness Offshore Fund

The primary investment objective of the scheme is to generate long-term capital growth by investing predominantly in units of overseas mutual funds, focusing on agriculture and/or would be direct and indirect beneficiaries of the anticipated growth in the agriculture and/or affiliated/allied sectors.

Research Highlights for PGIM India Global Agribusiness Offshore Fund

Upper mid AUM (₹1,511 Cr).
Established history (16+ yrs).
Rating: 1★ (bottom quartile).
Risk profile: High.
5Y return: 10.18% (bottom quartile).
3Y return: 20.88% (bottom quartile).
1Y return: 26.13% (lower mid).
1M return: 12.32% (lower mid).
Alpha: -25.56 (bottom quartile).
Sharpe: -0.04 (lower mid).
Information ratio: -0.65 (lower mid).

Below is the key information for PGIM India Global Agribusiness Offshore Fund

PGIM India Global Agribusiness Offshore Fund Growth
Launch Date	14 May 10
NAV (13 May 26)	₹52.32 ↑ 0.70 (1.36 %)
Net Assets (Cr)	₹1,511 on 28 Feb 26
Category	Others - Fund of Fund
AMC	Pramerica Asset Managers Private Limited
Rating	☆
Risk	High
Expense Ratio	1.56
Sharpe Ratio	-0.04
Information Ratio	-0.65
Alpha Ratio	-25.56
Min Investment	5,000
Min SIP Investment	1,000
Exit Load	0-12 Months (1%),12 Months and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
30 Apr 21	₹10,000
30 Apr 22	₹7,856
30 Apr 23	₹8,195
30 Apr 24	₹10,660
30 Apr 25	₹11,179
30 Apr 26	₹14,137

PGIM India Global Agribusiness Offshore Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹395,578.
Net Profit of ₹95,578 Invest Now

Returns for PGIM India Global Agribusiness Offshore Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 13 May 26

Duration	Returns
1 Month	12.3%
3 Month	17.5%
6 Month	12%
1 Year	26.1%
3 Year	20.9%
5 Year	10.2%
10 Year
15 Year
Since launch	10.9%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	7.9%
2023	24%
2022	39.5%
2021	-33.8%
2020	7%
2019	72.4%
2018	30.9%
2017	0.3%
2016	11.9%
2015	0.8%

Fund Manager information for PGIM India Global Agribusiness Offshore Fund

Name	Since	Tenure
Anandha Padmanabhan Anjeneyan	15 Feb 25	1.21 Yr.
Vivek Sharma	15 Feb 25	1.21 Yr.

Data below for PGIM India Global Agribusiness Offshore Fund as on 28 Feb 26

Asset Allocation

Asset Class	Value
Cash	8.02%
Equity	91.98%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
PGIM Jennison Global Eq Opps USD I Acc Investment Fund \| -	98%	₹1,418 Cr	518,221 ↓ -8,926
Clearing Corporation Of India Ltd. CBLO/Reverse Repo \| -	3%	₹42 Cr
Net Receivables / (Payables) Net Current Assets \| -	1%	-₹9 Cr

7. Franklin India Feeder - Franklin U S Opportunities Fund

The Fund seeks to provide capital appreciation by investing predominantly in units of Franklin U. S. Opportunities Fund, an overseas Franklin Templeton mutual fund, which primarily invests in securities in the United States of America.

Research Highlights for Franklin India Feeder - Franklin U S Opportunities Fund

Top quartile AUM (₹4,408 Cr).
Established history (14+ yrs).
Rating: 4★ (upper mid).
Risk profile: High.
5Y return: 13.31% (lower mid).
3Y return: 25.56% (lower mid).
1Y return: 28.01% (lower mid).
Alpha: -7.19 (lower mid).
Sharpe: 0.99 (lower mid).
Information ratio: -1.70 (bottom quartile).

Below is the key information for Franklin India Feeder - Franklin U S Opportunities Fund

Franklin India Feeder - Franklin U S Opportunities Fund Growth
Launch Date	6 Feb 12
NAV (13 May 26)	₹91.226 ↑ 0.96 (1.06 %)
Net Assets (Cr)	₹4,408 on 31 Mar 26
Category	Equity - Global
AMC	Franklin Templeton Asst Mgmt(IND)Pvt Ltd
Rating	☆☆☆☆
Risk	High
Expense Ratio	1.54
Sharpe Ratio	0.99
Information Ratio	-1.7
Alpha Ratio	-7.19
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-3 Years (1%),3 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
30 Apr 21	₹10,000
30 Apr 22	₹8,491
30 Apr 23	₹8,576
30 Apr 24	₹11,456
30 Apr 25	₹12,320
30 Apr 26	₹16,413

Franklin India Feeder - Franklin U S Opportunities Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹426,080.
Net Profit of ₹126,080 Invest Now

Returns for Franklin India Feeder - Franklin U S Opportunities Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 13 May 26

Duration	Returns
1 Month	11%
3 Month	17.2%
6 Month	16.1%
1 Year	28%
3 Year	25.6%
5 Year	13.3%
10 Year
15 Year
Since launch	16.8%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	11.4%
2023	27.1%
2022	37.9%
2021	-30.3%
2020	17.9%
2019	45.2%
2018	34.2%
2017	6.5%
2016	18.1%
2015	-0.8%

Fund Manager information for Franklin India Feeder - Franklin U S Opportunities Fund

Name	Since	Tenure
Sandeep Manam	18 Oct 21	4.53 Yr.

Data below for Franklin India Feeder - Franklin U S Opportunities Fund as on 31 Mar 26

Equity Sector Allocation

Sector	Value
Technology	40.89%
Communication Services	13.17%
Consumer Cyclical	13.16%
Health Care	10.3%
Industrials	8.13%
Financial Services	4.27%
Basic Materials	1.55%
Consumer Defensive	0.83%
Real Estate	0.51%

Asset Allocation

Asset Class	Value
Cash	1.28%
Equity	96.7%
Other	0.16%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Franklin US Opportunities I(acc)USD Investment Fund \| -	99%	₹4,359 Cr	4,886,238 ↑ 49,511
Call, Cash & Other Assets CBLO \| -	1%	₹49 Cr

8. UTI Healthcare Fund

(Erstwhile UTI Pharma & Healthcare Fund)

The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors.

Research Highlights for UTI Healthcare Fund

Lower mid AUM (₹1,056 Cr).
Oldest track record among peers (26 yrs).
Rating: 1★ (bottom quartile).
Risk profile: High.
5Y return: 14.38% (top quartile).
3Y return: 27.12% (upper mid).
1Y return: 13.24% (bottom quartile).
Alpha: -1.12 (lower mid).
Sharpe: -0.35 (bottom quartile).
Information ratio: -0.33 (upper mid).

Below is the key information for UTI Healthcare Fund

UTI Healthcare Fund Growth
Launch Date	28 Jun 99
NAV (14 May 26)	₹307.133 ↑ 6.45 (2.14 %)
Net Assets (Cr)	₹1,056 on 31 Mar 26
Category	Equity - Sectoral
AMC	UTI Asset Management Company Ltd
Rating	☆
Risk	High
Expense Ratio	2.26
Sharpe Ratio	-0.35
Information Ratio	-0.33
Alpha Ratio	-1.12
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
30 Apr 21	₹10,000
30 Apr 22	₹10,234
30 Apr 23	₹9,869
30 Apr 24	₹14,738
30 Apr 25	₹17,770
30 Apr 26	₹19,251

UTI Healthcare Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹436,710.
Net Profit of ₹136,710 Invest Now

Returns for UTI Healthcare Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 13 May 26

Duration	Returns
1 Month	9.9%
3 Month	10%
6 Month	6%
1 Year	13.2%
3 Year	27.1%
5 Year	14.4%
10 Year
15 Year
Since launch	14.8%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	-3.1%
2023	42.9%
2022	38.2%
2021	-12.3%
2020	19.1%
2019	67.4%
2018	1.2%
2017	-7.5%
2016	6.2%
2015	-9.7%

Fund Manager information for UTI Healthcare Fund

Name	Since	Tenure
Kamal Gada	2 May 22	4 Yr.

Data below for UTI Healthcare Fund as on 31 Mar 26

Equity Sector Allocation

Sector	Value
Health Care	94.69%
Basic Materials	0.57%

Asset Allocation

Asset Class	Value
Cash	4.75%
Equity	95.25%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Sun Pharmaceuticals Industries Ltd (Healthcare) Equity, Since 31 Oct 06 \| SUNPHARMA	9%	₹108 Cr	600,000
Ajanta Pharma Ltd (Healthcare) Equity, Since 31 Jul 17 \| 532331	6%	₹67 Cr	236,511 ↓ -4,345
Lupin Ltd (Healthcare) Equity, Since 28 Feb 25 \| 500257	4%	₹48 Cr	210,000 ↓ -60,000
Apollo Hospitals Enterprise Ltd (Healthcare) Equity, Since 30 Apr 21 \| APOLLOHOSP	4%	₹40 Cr	53,000
Divi's Laboratories Ltd (Healthcare) Equity, Since 30 Sep 17 \| DIVISLAB	3%	₹39 Cr	60,738
Glenmark Pharmaceuticals Ltd (Healthcare) Equity, Since 31 Mar 24 \| 532296	3%	₹38 Cr	159,440 ↓ -40,560
Dr Reddy's Laboratories Ltd (Healthcare) Equity, Since 28 Feb 18 \| DRREDDY	3%	₹38 Cr	290,000
Gland Pharma Ltd (Healthcare) Equity, Since 30 Nov 20 \| GLAND	3%	₹38 Cr	215,251
Fortis Healthcare Ltd (Healthcare) Equity, Since 31 Dec 20 \| 532843	3%	₹37 Cr	400,000
Alkem Laboratories Ltd (Healthcare) Equity, Since 31 May 21 \| ALKEM	3%	₹37 Cr	68,000

9. TATA India Pharma & Healthcare Fund

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.

Research Highlights for TATA India Pharma & Healthcare Fund

Upper mid AUM (₹1,229 Cr).
Established history (10+ yrs).
Not Rated.
Risk profile: High.
5Y return: 14.13% (upper mid).
3Y return: 23.93% (lower mid).
1Y return: 7.53% (bottom quartile).
Alpha: -7.59 (bottom quartile).
Sharpe: -0.53 (bottom quartile).
Information ratio: -0.64 (lower mid).

Below is the key information for TATA India Pharma & Healthcare Fund

TATA India Pharma & Healthcare Fund Growth
Launch Date	28 Dec 15
NAV (14 May 26)	₹31.5869 ↑ 0.54 (1.73 %)
Net Assets (Cr)	₹1,229 on 31 Mar 26
Category	Equity - Sectoral
AMC	Tata Asset Management Limited
Rating	Not Rated
Risk	High
Expense Ratio	2.17
Sharpe Ratio	-0.53
Information Ratio	-0.64
Alpha Ratio	-7.59
Min Investment	5,000
Min SIP Investment	150
Exit Load	0-3 Months (0.25%),3 Months and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
30 Apr 21	₹10,000
30 Apr 22	₹10,512
30 Apr 23	₹10,302
30 Apr 24	₹15,721
30 Apr 25	₹18,327
30 Apr 26	₹18,750

TATA India Pharma & Healthcare Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹436,710.
Net Profit of ₹136,710 Invest Now

Returns for TATA India Pharma & Healthcare Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 13 May 26

Duration	Returns
1 Month	9.5%
3 Month	7.2%
6 Month	2.2%
1 Year	7.5%
3 Year	23.9%
5 Year	14.1%
10 Year
15 Year
Since launch	11.7%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	-4.9%
2023	40.4%
2022	36.6%
2021	-8%
2020	19.1%
2019	64.4%
2018	5.5%
2017	-2.6%
2016	4.7%
2015	-14.7%

Fund Manager information for TATA India Pharma & Healthcare Fund

Name	Since	Tenure
Rajat Srivastava	16 Sep 24	1.62 Yr.

Data below for TATA India Pharma & Healthcare Fund as on 31 Mar 26

Equity Sector Allocation

Sector	Value
Health Care	93.72%
Basic Materials	5.19%
Financial Services	0.67%

Asset Allocation

Asset Class	Value
Cash	0.42%
Equity	99.58%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Sun Pharmaceuticals Industries Ltd (Healthcare) Equity, Since 31 Jan 16 \| SUNPHARMA	10%	₹131 Cr	723,130
Divi's Laboratories Ltd (Healthcare) Equity, Since 30 Sep 17 \| DIVISLAB	6%	₹78 Cr	120,600
HealthCare Global Enterprises Ltd (Healthcare) Equity, Since 31 Dec 18 \| HCG	5%	₹72 Cr	1,261,727
Abbott India Ltd (Healthcare) Equity, Since 30 Sep 25 \| ABBOTINDIA	5%	₹71 Cr	27,953
Max Healthcare Institute Ltd Ordinary Shares (Healthcare) Equity, Since 31 Jul 25 \| MAXHEALTH	5%	₹69 Cr	690,488 ↑ 33,742
Cipla Ltd (Healthcare) Equity, Since 30 Apr 20 \| 500087	5%	₹67 Cr	512,754 ↑ 150
Rainbow Childrens Medicare Ltd (Healthcare) Equity, Since 31 Jul 25 \| 543524	4%	₹56 Cr	447,133
Apollo Hospitals Enterprise Ltd (Healthcare) Equity, Since 31 Dec 16 \| APOLLOHOSP	4%	₹54 Cr	70,484
Mankind Pharma Ltd (Healthcare) Equity, Since 30 Apr 23 \| MANKIND	4%	₹49 Cr	220,018 ↑ 973
Dr Reddy's Laboratories Ltd (Healthcare) Equity, Since 31 Aug 18 \| DRREDDY	4%	₹49 Cr	373,464 ↑ 35,868

10. Nippon India Pharma Fund

The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.

Research Highlights for Nippon India Pharma Fund

Highest AUM (₹7,898 Cr).
Established history (21+ yrs).
Rating: 2★ (lower mid).
Risk profile: High.
5Y return: 13.65% (upper mid).
3Y return: 24.03% (lower mid).
1Y return: 9.90% (bottom quartile).
Alpha: 0.02 (top quartile).
Sharpe: -0.25 (bottom quartile).
Information ratio: -0.77 (bottom quartile).

Below is the key information for Nippon India Pharma Fund

Nippon India Pharma Fund Growth
Launch Date	5 Jun 04
NAV (14 May 26)	₹542.651 ↑ 10.80 (2.03 %)
Net Assets (Cr)	₹7,898 on 31 Mar 26
Category	Equity - Sectoral
AMC	Nippon Life Asset Management Ltd.
Rating	☆☆
Risk	High
Expense Ratio	1.81
Sharpe Ratio	-0.25
Information Ratio	-0.77
Alpha Ratio	0.02
Min Investment	5,000
Min SIP Investment	100
Exit Load	0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
30 Apr 21	₹10,000
30 Apr 22	₹10,384
30 Apr 23	₹10,256
30 Apr 24	₹15,499
30 Apr 25	₹17,974
30 Apr 26	₹18,700

Nippon India Pharma Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹426,080.
Net Profit of ₹126,080 Invest Now

Returns for Nippon India Pharma Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 13 May 26

Duration	Returns
1 Month	9.2%
3 Month	8%
6 Month	4.5%
1 Year	9.9%
3 Year	24%
5 Year	13.6%
10 Year
15 Year
Since launch	20%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	-3.3%
2023	34%
2022	39.2%
2021	-9.9%
2020	23.9%
2019	66.4%
2018	1.7%
2017	3.6%
2016	7.6%
2015	-10.6%

Fund Manager information for Nippon India Pharma Fund

Name	Since	Tenure
Sailesh Raj Bhan	1 Apr 05	21.1 Yr.
Kinjal Desai	25 May 18	7.94 Yr.
Amber Singhania	11 Mar 26	0.14 Yr.

Data below for Nippon India Pharma Fund as on 31 Mar 26

Equity Sector Allocation

Sector	Value
Health Care	98.68%

Asset Allocation

Asset Class	Value
Cash	1.32%
Equity	98.68%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Sun Pharmaceuticals Industries Ltd (Healthcare) Equity, Since 31 Oct 09 \| SUNPHARMA	14%	₹1,158 Cr	6,406,349 ↑ 150,000
Lupin Ltd (Healthcare) Equity, Since 31 Aug 08 \| 500257	8%	₹665 Cr	2,883,991
Dr Reddy's Laboratories Ltd (Healthcare) Equity, Since 30 Jun 11 \| DRREDDY	7%	₹589 Cr	4,449,746 ↑ 700,000
Divi's Laboratories Ltd (Healthcare) Equity, Since 31 Mar 12 \| DIVISLAB	7%	₹553 Cr	850,754
Cipla Ltd (Healthcare) Equity, Since 31 May 08 \| 500087	5%	₹458 Cr	3,495,054
Apollo Hospitals Enterprise Ltd (Healthcare) Equity, Since 30 Sep 20 \| APOLLOHOSP	5%	₹419 Cr	548,795
Medplus Health Services Ltd (Healthcare) Equity, Since 30 Nov 22 \| MEDPLUS	4%	₹316 Cr	3,627,277
Vijaya Diagnostic Centre Ltd (Healthcare) Equity, Since 30 Sep 21 \| VIJAYA	3%	₹281 Cr	2,486,684 ↓ -400,000
Sai Life Sciences Ltd (Healthcare) Equity, Since 31 Dec 24 \| SAILIFE	3%	₹273 Cr	2,555,745
Ajanta Pharma Ltd (Healthcare) Equity, Since 30 Apr 22 \| 532331	3%	₹267 Cr	946,323

11. DSP World Energy Fund

The primary investment objective of the Scheme is to seek capital appreciation by investing predominantly in the units of BlackRock Global Funds – World Energy Fund and BlackRock Global Funds – New Energy Fund. The Scheme may, at the discretion of the Investment Manager, also invest in the units of other similar overseas mutual fund schemes, which may constitute a significant part of its corpus. The Scheme may also invest a certain portion of its corpus in money market securities and/or money market/liquid schemes of DSP BlackRock Mutual Fund, in order to meet liquidity requirements from time to time.

Research Highlights for DSP World Energy Fund

Bottom quartile AUM (₹104 Cr).
Established history (16+ yrs).
Rating: 2★ (lower mid).
Risk profile: High.
5Y return: 14.20% (upper mid).
3Y return: 20.00% (bottom quartile).
1Y return: 71.21% (top quartile).
Alpha: 0.00 (upper mid).
Sharpe: 3.63 (top quartile).
Information ratio: 0.00 (top quartile).

Below is the key information for DSP World Energy Fund

DSP World Energy Fund Growth
Launch Date	14 Aug 09
NAV (13 May 26)	₹30.7211 ↑ 0.51 (1.70 %)
Net Assets (Cr)	₹104 on 31 Mar 26
Category	Equity - Global
AMC	DSP BlackRock Invmt Managers Pvt. Ltd.
Rating	☆☆
Risk	High
Expense Ratio	1.18
Sharpe Ratio	3.63
Information Ratio	0
Alpha Ratio	0
Min Investment	1,000
Min SIP Investment	500
Exit Load	0-12 Months (1%),12 Months and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
30 Apr 21	₹10,000
30 Apr 22	₹9,570
30 Apr 23	₹11,122
30 Apr 24	₹11,109
30 Apr 25	₹10,066
30 Apr 26	₹18,831

DSP World Energy Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹436,710.
Net Profit of ₹136,710 Invest Now

Returns for DSP World Energy Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 13 May 26

Duration	Returns
1 Month	8.9%
3 Month	15.3%
6 Month	33.3%
1 Year	71.2%
3 Year	20%
5 Year	14.2%
10 Year
15 Year
Since launch	6.9%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	39.2%
2023	-6.8%
2022	12.9%
2021	-8.6%
2020	29.5%
2019	0%
2018	18.2%
2017	-11.3%
2016	-1.9%
2015	22.5%

Fund Manager information for DSP World Energy Fund

Name	Since	Tenure
Kaivalya Nadkarni	1 May 25	1 Yr.

Data below for DSP World Energy Fund as on 31 Mar 26

Equity Sector Allocation

Sector	Value
Industrials	33.1%
Utility	25.15%
Technology	23.3%
Basic Materials	10.39%
Consumer Cyclical	0.71%

Asset Allocation

Asset Class	Value
Cash	7.34%
Equity	92.64%
Debt	0.02%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
BGF Sustainable Energy I2 Investment Fund \| -	96%	₹100 Cr	404,670
Treps / Reverse Repo Investments CBLO/Reverse Repo \| -	4%	₹4 Cr
Net Receivables/Payables Net Current Assets \| -	0%	₹0 Cr

Disclaimer:
இங்கு வழங்கப்பட்ட தகவல்கள் துல்லியமானவை என்பதை உறுதிப்படுத்த அனைத்து முயற்சிகளும் மேற்கொள்ளப்பட்டுள்ளன. இருப்பினும், தரவுகளின் சரியான தன்மை குறித்து எந்த உத்தரவாதமும் அளிக்கப்படவில்லை. முதலீடு செய்வதற்கு முன் திட்டத் தகவல் ஆவணத்துடன் சரிபார்க்கவும்.